Disclaimer

H-CYTE maintains this website as a service to the financial and internet communities except for the Investors section, which is maintained by Equisolve, a third-party service provider. The site is intended to provide general information about the Company. It is not designed to be a source for making investment decisions. It is also not designed to be a source for making medical decisions. H-CYTE will make every reasonable effort to include accurate and current information on this website.

Except for the historical information contained herein, the information on the site may include forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. More complete information is contained in the Company’s Securities and Exchange Commission (SEC) filings which are available at SEC.gov.

Neither H-CYTE nor any party involved in creating, producing or delivering this site shall be liable for any direct, incidental, consequential, indirect or punitive damages arising out of the user’s access, use or liability to use the Company’s website, or any errors or omissions in the content of the H-CYTE website.

Terms of Use General

H-CYTE (“the Company”) has made a reasonable effort to provide accurate and current information on this website.

It is important to note that nothing on our website constitutes or should be construed as investment advice. Date and information presented is not furnished in connection with any sale, offer of sale, solicitation or an offer to buy a security.

The H-CYTE website does not, and is not intended to, provide medical advice, nor does it provide instruction on the appropriate use of any product produced or supplied by H-CYTE or its affiliates, licensors or joint venture partners.

Privacy and Security

We respect your privacy. We have implemented measures designed to protect against unauthorized access, interception, loss, misuse and/or alteration of the information under our control but cannot guarantee that events of unauthorized access, interception, loss, misuse and/or alteration of the information under our control will not occur. Please refer to our Privacy Policy available on this website for further information.

Solicitation Policy

Neither H-CYTE nor any of its employees accept or consider unsolicited ideas regarding marketing, technologies or product names. The goal is to avoid any potential misunderstandings when H-CYTE’s products or marketing strategies might appear similar to ideas submitted to the Company.

No Offer or Advice

The Investor Relations section of this website does not constitute an offer to sell or a solicitation of an offer to buy any security referenced on this website. H-CYTE’s management never represents that a security, product or service discussed here, is suitable for any particular investor. We do not guarantee the accuracy, completeness or timeliness of the information on this website. We strongly advise that all individuals be aware of the risks involved in every business and stock. You can help protect yourself by being an educated investor by closely examining Company documents filed with the SEC as well as all other documents that have been published which are available at SEC.gov.

Limitation of Liability – SEC Rule 606

Use of this website is at the viewer’s own risk. Its content including, but not limited to, any graphics, links or other terms are provided on an “as is” basis without warranties or representations of any kind. The Company expressly disclaims any liability for any errors or omissions in the content included in this website. All changes (should and when they may occur) are effective immediately upon posting to this website.

Archived and Forward-Looking Information

Any reports filed with the SEC may contain forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve risks, some of which may be outside the Company’s control and may include economic, political and market fluctuations. H-CYTE undertakes no obligation to update or revise publicly any forward-looking statement whether as a result of new information, future events or otherwise.

The Company strongly recommends readers carefully review all other documents and periodic reports filed by the Company with the SEC which are available at SEC.gov.

H-CYTE cannot and does not guarantee or warrant that files available for downloading (if any) through this site will be free of infection by software viruses or other harmful computer code, files or programs. 

News and Press Releases

This H-CYTE website may contain information, news and /or press releases, the content of which is accurate and current only as of the date of the particular information, news, press release or posting. H-CYTE does not update press releases once they have been made public.

Copyright

H-CYTE and its affiliates and subsidiaries names, logos and all product names and the entire content of this website, including images or text, are protected by copyright. You may download material from this website for personal use only. The use or misuse of copyright and trademarks is expressly prohibited and may be in violation of copyright law, trademark law, communications regulations and statutes, and other laws or regulations.

Florida Law and Forum. LHI reserves the right to modify the terms and conditions of this Agreement at any time, and such modifications shall be effective immediately upon posting of the modified Agreement. Your continued access to the Website shall be deemed to be conclusive acceptance of the modified Agreement.

Third Party Websites

This website may include links to websites maintained or controlled by non-H-CYTE, affiliate or subsidiary parties. H-CYTE is not responsible for and does not routinely screen, approve, review or endorse third party content.

How to Contact Us:
H-CYTE, Inc
Attention: Compliance Officer
201 E. Kennedy Blvd. Suite 700
Tampa, FL 33602